230 related articles for article (PubMed ID: 12477251)
21. Systemic tumor-targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes.
Urnauer S; Klutz K; Grünwald GK; Morys S; Schwenk N; Zach C; Gildehaus FJ; Rödl W; Ogris M; Wagner E; Spitzweg C
J Gene Med; 2017 May; 19(5):. PubMed ID: 28423213
[TBL] [Abstract][Full Text] [Related]
22. Establishment and characterization of a breast cancer cell line expressing Na+/I- symporters for radioiodide concentrator gene therapy.
Nakamoto Y; Saga T; Misaki T; Kobayashi H; Sato N; Ishimori T; Kosugi S; Sakahara H; Konishi J
J Nucl Med; 2000 Nov; 41(11):1898-904. PubMed ID: 11079502
[TBL] [Abstract][Full Text] [Related]
23. Radioiodide imaging and treatment of ARO cancer xenograft in a mouse model after expression of human sodium iodide symporter.
Hsieh YJ; Ke CC; Liu RS; Wang FH; Tang KT; Chi CW; Chen FD; Lee CH
Anticancer Res; 2007; 27(4B):2515-22. PubMed ID: 17695547
[TBL] [Abstract][Full Text] [Related]
24. Mesenchymal Stem Cell-mediated Image-guided Sodium Iodide Symporter (NIS) Gene Therapy Improves Survival of Glioblastoma-bearing Mice.
Kitzberger C; Spellerberg R; Han Y; Schmohl KA; Stauss C; Zach C; Kälin RE; Multhoff G; Eiber M; Schilling F; Glass R; Weber WA; Wagner E; Nelson PJ; Spitzweg C
Clin Cancer Res; 2023 Mar; 29(5):930-942. PubMed ID: 36516189
[TBL] [Abstract][Full Text] [Related]
25. Baculovirus vector-mediated transfer of sodium iodide symporter and plasminogen kringle 5 genes for tumor radioiodide therapy.
Zhang M; Guo R; Shi S; Miao Y; Zhang Y; Li B
PLoS One; 2014; 9(3):e92326. PubMed ID: 24647588
[TBL] [Abstract][Full Text] [Related]
26. Effects of theophylline on radioiodide uptake in MCF-7 breast cancer and NIS gene-transduced SNU-C5 colon cancer cells.
Yoon JK; Park BN; Paik JY; Jung KH; Ko BH; Lee KH
Cancer Biother Radiopharm; 2009 Apr; 24(2):201-8. PubMed ID: 19409042
[TBL] [Abstract][Full Text] [Related]
27. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.
Reddi HV; Madde P; McDonough SJ; Trujillo MA; Morris JC; Myers RM; Peng KW; Russell SJ; McIver B; Eberhardt NL
Cancer Gene Ther; 2012 Sep; 19(9):659-65. PubMed ID: 22790962
[TBL] [Abstract][Full Text] [Related]
28. In vivo expression and function of the sodium iodide symporter following gene transfer in the MATLyLu rat model of metastatic prostate cancer.
La Perle KM; Shen D; Buckwalter TL; Williams B; Haynam A; Hinkle G; Pozderac R; Capen CC; Jhiang SM
Prostate; 2002 Feb; 50(3):170-8. PubMed ID: 11813209
[TBL] [Abstract][Full Text] [Related]
29. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy.
Boland A; Ricard M; Opolon P; Bidart JM; Yeh P; Filetti S; Schlumberger M; Perricaudet M
Cancer Res; 2000 Jul; 60(13):3484-92. PubMed ID: 10910060
[TBL] [Abstract][Full Text] [Related]
30. microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake.
Lakshmanan A; Wojcicka A; Kotlarek M; Zhang X; Jazdzewski K; Jhiang SM
Endocr Relat Cancer; 2015 Feb; 22(1):11-21. PubMed ID: 25404690
[TBL] [Abstract][Full Text] [Related]
31. Sodium iodide symporter: its role in nuclear medicine.
Chung JK
J Nucl Med; 2002 Sep; 43(9):1188-200. PubMed ID: 12215558
[TBL] [Abstract][Full Text] [Related]
32. The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics.
Kogai T; Brent GA
Pharmacol Ther; 2012 Sep; 135(3):355-70. PubMed ID: 22750642
[TBL] [Abstract][Full Text] [Related]
33. Accuracy of myocardial sodium/iodide symporter gene expression imaging with radioiodide: evaluation with a dual-gene adenovirus vector.
Lee KH; Kim HK; Paik JY; Matsui T; Choe YS; Choi Y; Kim BT
J Nucl Med; 2005 Apr; 46(4):652-7. PubMed ID: 15809488
[TBL] [Abstract][Full Text] [Related]
34. Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.
Li W; Tan J; Wang P; Wu P
Cancer Biother Radiopharm; 2011 Aug; 26(4):443-51. PubMed ID: 21797672
[TBL] [Abstract][Full Text] [Related]
35. Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two-and three-dimensional models.
Carlin S; Cunningham SH; Boyd M; McCluskey AG; Mairs RJ
Cancer Gene Ther; 2000 Dec; 7(12):1529-36. PubMed ID: 11228531
[TBL] [Abstract][Full Text] [Related]
36. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
[TBL] [Abstract][Full Text] [Related]
37. In vivo molecular imaging and radionuclide (131I) therapy of human nasopharyngeal carcinoma cells transfected with a lentivirus expressing sodium iodide symporter.
Shi S; Zhang M; Guo R; Miao Y; Hu J; Xi Y; Li B
PLoS One; 2015; 10(1):e0116531. PubMed ID: 25621996
[TBL] [Abstract][Full Text] [Related]
38. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
Spitzweg C; O'Connor MK; Bergert ER; Tindall DJ; Young CY; Morris JC
Cancer Res; 2000 Nov; 60(22):6526-30. PubMed ID: 11103823
[TBL] [Abstract][Full Text] [Related]
39. Regression of experimental NIS-expressing breast cancer brain metastases in response to radioiodide/gemcitabine dual therapy.
Renier C; Do J; Reyna-Neyra A; Foster D; De A; Vogel H; Jeffrey SS; Tse V; Carrasco N; Wapnir I
Oncotarget; 2016 Aug; 7(34):54811-54824. PubMed ID: 27363025
[TBL] [Abstract][Full Text] [Related]
40. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
